gms | German Medical Science

57th Annual Meeting of the German Society of Neurosurgery
Joint Meeting with the Japanese Neurosurgical Society

German Society of Neurosurgery (DGNC)

11 - 14 May, Essen

First clinical experiences and results concerning the new rechargeable stimulation device RESTORE™ for spinal cord stimulation

Erste klinische Erfahrungen mit dem neuen wiederaufladbaren Stimulationssystem RESTORE™ zur epiduralen Rückenmarkstimulation

Meeting Abstract

Search Medline for

  • corresponding author D. Rasche - Neurochirurgische Klinik, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
  • D. Foethke - Neurochirurgische Klinik, Universitätsklinikum Schleswig-Holstein, Campus Lübeck
  • V.M. Tronnier - Neurochirurgische Klinik, Universitätsklinikum Schleswig-Holstein, Campus Lübeck

Deutsche Gesellschaft für Neurochirurgie. Japanische Gesellschaft für Neurochirurgie. 57. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie e.V. (DGNC), Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie. Essen, 11.-14.05.2006. Düsseldorf, Köln: German Medical Science; 2006. DocP 02.18

The electronic version of this article is the complete one and can be found online at:

Published: May 8, 2006

© 2006 Rasche et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



Objective: Spinal cord stimulation (SCS) is an alternative and invasive treatment option for patients with chronic radicular neuropathic pain. Since December 2004 a newly developed device for SCS with a rechargeable neurostimulator is available. The first clinical experiences and results of seven patients are presented.

Methods: In seven patients (2 female, 5 male) SCS was indicated because of therapeutically refractory chronic radicular neuropathic pain. In five cases a failed back surgery syndrome, in one case each a peripheral arterial vessel disease and a radicular thoracic neuropathic pain was diagnosed. Using local anaesthesia the new electrode with eight contacts was inserted epidurally and a test trial conducted. Pain intensity was documented using the visual analogue scale (VAS).

Results: In all patients it was possible to place the electrode and cover the painful areas with pleasant paraesthesias. During the test trial the patients were able to modulate the stimulation parameters using a newly developed patient programmer. In all patients SCS was able to reduce pain intensity by >50% of the initial VAS and oral pain medication. The rechargeable stimulation device was implanted subcutaneously using general anaesthesia. All patients were able to recharge the devices percutaneously by using a special belt including a magnetic induction coil. No hard-, software or material deficits, nor wound infections were observed.

Conclusions: The newly developed stimulation device Restore™ is a safe and effective system for SCS and allows a better individual setting of the stimulation parameters. The long-term results concerning an battery longevity of 9 years need to be investigated.